Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Fitness Franchise Industry Trends For The Year 2021 And Beyond


Team Alloy

Alloy Personal Training Franchise Leadership Team: Jared Breen, Matt Helland, Suzanne Robb, and Rick Mayo

“The right concepts and unprecedented access to inexpensive capital, inexpensive and high profile locations, along with the coming economic boom associated with new vaccines and therapies to counter COVID, thus ending the pandemic, are going to create a great opportunity for fitness entrepreneurs.”

Alloy Personal Training, an emerging personal training fitness studio franchise, announced their FREE franchise webinar: Fitness Franchise Trends For 2021 and Beyond, which will occur on Tuesday, December 1, 2020, 12:00 PM Mountain/ 2:00 PM Eastern Time (U.S. and Canada).

Fitness franchises have exploded in the past decade, and despite setbacks resulting from COVID, another round of growth is anticipated for the right franchised fitness concepts in 2021 and beyond.

Whether taking a group fitness class or joining a low price gym, over the past decade, a massive shift impacted the global fitness industry through the creation of a landscape of franchised fitness businesses.

This shift to franchises in the fitness industry was being driven by various trends reflected in most consumer-facing industries: a bifurcation of market offerings including more premium and low-cost options and a surge in people seeking to be in business for themself but not by themself.

Alloy Personal Training’s founder Rick Mayo, in collaboration with Fitness Industry Technology Council’s, Bryan O’Rourke, invites professionals in the health club and gym space and people interested in learning more about fitness franchise opportunities to a conversation on recent trends regarding fitness franchises and what to expect in 2021 and beyond.

Topics will include:

1. Why will the right fitness franchises see incredible growth?

2. What is expected for the post-pandemic fitness franchise space?

3. Why will certain fitness franchise concepts perform better than others?

Panelists will include:

Bryan O’Rourke, CEO of FIT-C and Vedere Ventures, an experienced expert on franchising and a thought leader in technology and trends in the health and fitness industry, shared his thoughts, “Fitness franchises are going to see clear winners and losers in the years ahead. The right concepts combined with unprecedented access to inexpensive capital, inexpensive and high profile locations, along with the coming economic boom associated with new vaccines and therapies to counter COVID, thus ending the pandemic, are going to create a great opportunity for fitness entrepreneurs.”

For registration and more information, please follow the link to Register Here.

# # #

About Alloy Personal Training Franchise

Alloy’s fitness program was created in 1992 around a very straightforward philosophy: people who get personalized coaching get better results. The Alloy systems, platforms, and know-how have already been used to serve millions of members in thousands of fitness facilities worldwide and was recently awarded the AFS Fitness Business of the Year.

Alloy’s established, effective fitness platform and business management solutions have delivered real results throughout the world. Alloy Personal Training Franchise gives franchisees the chance to impact their community and their future with a branded, brick-and-mortar Alloy Personal Training franchise location.

Today, Alloy programs are among the most effective programs in the world for helping people who want to look and feel their absolute best. Learn more at http://alloyfranchise.com

About The Fitness Industry Technology Council

The Fitness Industry Technology Council is a not for profit consortium of leading professionals and organizations representing the fitness industry. The council seeks to grow the fitness industry, improve fitness user experience through thoughtful adoption of technologies, and mature the collection of real-time wellness data through the creation of interoperability standards.

FITC’s headquarters are located in the New Orleans, Louisiana area.

http://www.fittechcouncil.org/

About Rick Mayo

Rick Mayo is an accomplished fitness business entrepreneur and founder and CEO of the Alloy Personal Training Franchise.

Rick’s business journey began with his original personal training studio, which opened in 1992 and is still going strong, having delivered exceptional fitness experiences to tens of thousands of clients in the Roswell, Georgia area. In 2010 Rick started Alloy, a personal training business platform. As a result of Alloy’s combination of customized client programs, business systems, and technology tools, leading health club and gym brands adopted the Alloy model. It rapidly grew to serve over 1,000 licensed fitness facilities worldwide. With years of experience deploying the Alloy systems under their belt Mayo and his team took the next logical step by launching the Alloy Personal Training franchise in 2019 to deliver a turnkey opportunity encompassing the entire personal training business model from build-out design through equipment, business systems, technology platforms, marketing, and more.

Rick, a fitness entrepreneur, has delivered keynotes on personal training and fitness business trends to audiences worldwide. He has also been an advisor to organizations like the Gold’s Gym Franchisee Association and the American Council on Exercise, among others.

Rick and his Alloy Personal Training Business team have signed several development agreements and are in talks to develop several additional markets. To learn more, visit http://www.alloyfranchise.com.

Share article on social media or email:

Icahn School of Medicine at Mount Sinai and Boehringer Ingelheim Collaborate on First Study to Evaluate nintedanib in Patients with Fibrosing ILD Following COVID-19


The Icahn School of Medicine at Mount Sinai, Department of Medicine’s Clinical Trials Office in collaboration with Boehringer Ingelheim today announced the first patient has enrolled in a new clinical study to investigate the effect of nintedanib in adult patients having acute lung injury following COVID-19 infection.

“A significant percentage of COVID-19 patients with acute lung injury may develop lung fibrosis based on clinical observations,” said Maria Padilla, M.D., primary investigator, director of the Advanced Lung & Interstitial Lung Disease Program at the Icahn School of Medicine at Mount Sinai. “Our team of researchers and our partner Boehringer Ingelheim share a commitment to improving outcomes in this vulnerable patient population.”

The study, called ENDCOV-I (Early Nintedanib Deployment in COVID-19 Interstitial Fibrosis) [NCT04619680 ], is a randomized, double-blinded, placebo-controlled study conducted at the Icahn School of Medicine to investigate the development and course of pulmonary fibrosis in 120 patients receiving nintedanib or placebo who have acute lung injury secondary to COVID-19 infection, and who required invasive or noninvasive respiratory support.

The primary endpoint of the study is percent change in forced vital capacity (FVC), a measurement of lung function, compared to baseline over six months (180 days). Secondary endpoints include change from baseline FVC at 90 days, death within 90 days and 180 days from enrollment due to respiratory or any cause and qualitative and quantitative change in chest CT fibrosis score graded by blinded chest radiologists.

“Boehringer Ingelheim is committed to fighting COVID-19 and proud to partner with Mount Sinai on this important clinical initiative,” said Craig Conoscenti, M.D., medical expert, Interstitial Lung Disease Medical Leader, Chronic Fibrosing ILD Program, Clinical Development and Medical Affairs, Boehringer Ingelheim. “The insights gained from this collaborative research program will help our understanding patients at high risk of pulmonary fibrosis in the COVID-19 patient population.”

“Boehringer Ingelheim is committed to fighting COVID-19 and proud to partner with Mount Sinai on this important clinical initiative,” said Craig Conoscenti, M.D., medical expert, Interstitial Lung Disease Medical Leader, Chronic Fibrosing ILD Program Clinical Development and Medical Affairs, Boehringer Ingelheim. “The insights that we learn from this collaborative research program will be critical to understanding whether treatment can help patients at high risk of pulmonary complications resulting from COVID-19.”

Mount Sinai’s commitment against COVID-19

Throughout the course of the COVID-19 outbreak in New York, Mount Sinai has been at the forefront of understanding, researching and treating the disease. We have helped large numbers of people recover from the virus, and we have learned and enhanced the knowledge of this infection and manifestations along the way. We have recognized the multi-systemic nature of the disease and the lingering effects that continue to impact the patients. This has led to the establishment of the multidisciplinary Center For Post-COVID Care. We are committed to bringing information as it comes to light and to pursue investigation and scientifically based modalities of treatment and care.

Find out what Mo​unt Sinai researchers, doctors, and service providers are learning — and doing — about the novel coronavirus here.

BI commitment against COVID-19

As a research-driven company, Boehringer Ingelheim is part of the collective effort in fighting COVID-19. Drawing from its areas of scientific expertise, the company has engaged in a number of activities to find medical solutions to this pandemic, working closely with academic researchers, international institutions, and others in the pharma industry.

Boehringer Ingelheim is currently involved in a broad set of initiatives to fight the disease and save patients’ lives, including the research and development of SARS-CoV-2 antibodies that can neutralize the virus, small molecules to inhibit its replication, and therapy development to prevent microcoagulation (blood clots). The company recently began a Phase 2 clinical trial of a novel, targeted therapy to help people with severe respiratory illness from COVID-19.

Boehringer Ingelheim is also an active participant in the global access initiative with the Bill and Melinda Gates Foundation as well as global development initiatives including the COVID-19 Therapeutics Accelerator (CTA) and the CARE Consortium.

About nintedanib

Nintedanib is approved in the U.S. for the treatment of idiopathic pulmonary fibrosis (IPF) and available as Ofev®. In September 2019, nintedanib was approved in the U.S. to slow the rate of decline in pulmonary function in patients with SSc-ILD, and then in March 2020 to treat chronic fibrosing ILDs with a progressive phenotype.

About The Mount Sinai Department of Medicine Clinical Trials Office (MCTO)

Established in 2004, the mission of the MCTO is to provide centralized services for infrastructure and operational support to carry out industry and multicenter network clinical trials with the partnership of the Department of Medicine faculty. The staff have clinical research expertise to provide institutional and federal guidelines for clinical research.

For more information about this study, please email ENDCOVI@mssm.edu or call 646-819-1662.

About Boehringer Ingelheim

Making new and better medicines for humans and animals is at the heart of what we do. Our mission is to create breakthrough therapies that change lives. Since its founding in 1885, Boehringer Ingelheim is independent and family-owned. We have the freedom to pursue our long-term vision, looking ahead to identify the health challenges of the future and targeting those areas of need where we can do the most good.

As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. In 2019, Boehringer Ingelheim achieved net sales of around $21.3 billion (19 billion euros). Our significant investment of over $3.9 billion (3.5 billion euros) in R&D drives innovation, enabling the next generation of medicines that save lives and improve quality of life.

We realize more scientific opportunities by embracing the power of partnership and diversity of experts across the life-science community. By working together, we accelerate the delivery of the next medical breakthrough that will transform the lives of patients now, and in generations to come.

Boehringer Ingelheim Pharmaceuticals, Inc., based in Ridgefield, CT, is the largest U.S. subsidiary of Boehringer Ingelheim Corporation and is part of the Boehringer Ingelheim group of companies. In addition, there are Boehringer Ingelheim Animal Health in Duluth, GA and Boehringer Ingelheim Fremont, Inc. in Fremont, CA.

Boehringer Ingelheim is committed to improving lives and strengthening our communities. Please visit http://www.boehringer-ingelheim.us/csr to learn more about Corporate Social Responsibility initiatives.

For more information, please visit http://www.boehringer-ingelheim.us, or follow us on Twitter @BoehringerUS.



American College of Lifestyle Medicine Announces Addition of Plant-Based Food Brands Certifier Plantricious to Its Lifestyle Medicine Corporate Roundtable


News Image

“This partnership forges a new way to help physicians and other health care professionals fulfill the food-as-medicine promise.”

The American College of Lifestyle Medicine (ACLM) has announced the addition of plant-based food brands certifier Plantricious to its Corporate Roundtable. The Corporate Roundtable convenes thought leaders and industry professionals to explore effective clinical innovations, activate marketing strategies, accelerate reimbursement and policy adoption, and pursue research and demonstrations of Lifestyle Medicine in practice. Plantricious, which certifies plant-based food brands based on strictly defined, evidence-based nutrition guidelines, helps the public and health professionals in making food-as-medicine decisions.

The Roundtable launched in 2015 and has grown to include more than 30 active member organizations. In pursuit of sharing scientific findings and best practices, Plantricious will now work alongside fellow roundtable members and key leaders within ACLM as a contributing partner and will play an active role at ACLM’s annual conference.

It is widely recognized that a lifestyle including a predominantly whole food plant-based diet may help prevent, arrest, or even reverse chronic diseases such as heart disease, stroke, type 2 diabetes and cancer. According to the International Food Information Council, while 78% of consumers change their eating habits per their health care professional’s recommendation, patients can find it difficult to gauge the nutritional merits of plant-based options. The Plantricious seal is the first certification that makes it easy for consumers to find brands that meet a strict criteria of being 100% whole food plant-based, minimally processed, have no added oils, sugar, or artificial flavors and preservatives, while also containing a maximum of 1miligram of sodium per calorie and containing a minimum of 2 grams of fiber per 100 calories.

“This partnership also offers many new opportunities for Plantricious certified brands to connect with the 5,000-plus clinicians who are members of ACLM,” said Plantricious founder and CEO Paige Ohliger. “Given physicians see an average of 3,000 to 6,000 patients a year and there are almost 1 million practicing physicians in the U.S., there are endless possibilities to mutually benefit food companies as well as medical professionals and patients. “

“This strategic partnership creates a first-of-a-kind bridge between the health care community and Plantricious certified brands, forging a new way to help physicians and other health care professionals fulfill the food-as-medicine promise,” said ACLM President Cate Collings, MD, FACC, MS, DipABLM. “The Plantricious seal offers a simple way to identify health-promoting, nutritious foods that physicians and other health professionals can trust and rely upon when directing their patients to make healthful, plant-nutritious choices.”

“We worked with the nation’s leading health care experts to define the Plantricious seal standards, so ACLM was a natural fit to join our mission in providing a trusted and transparent way to identify plant-nutritious foods,” said Ohliger. “Our carefully cultivated ecosystem also gives food brands access to a thriving community of health care practitioners and health conscious consumers, helping us all to live more healthfully.”

ABOUT ACLM: The American College of Lifestyle Medicine (ACLM) is the medical professional society for those dedicated to the advancement and clinical practice of Lifestyle Medicine as the foundation of a transformed and sustainable health care system. Lifestyle Medicine is the use of an evidence-based whole food, plant-predominant dietary lifestyle, regular physical activity, restorative sleep, stress management, avoidance of risky substances and positive social connection as a primary therapeutic modality for treatment and reversal of chronic disease. Learn more at http://www.lifestylemedicine.org.

ABOUT PLANTRICIOUS: Plantricious is on a mission to make plant-nutritious food choices easy. Our Plantricious seal provides the food industry and the public a trusted and transparent way to identify healthy, plant-nutritious foods, and our curated ecosystem provides food brands with access to a large community of health care practitioners and health-conscious consumers. Learn more at http://www.plantricious.com.

Share article on social media or email:

National Health Care Associates Welcomes Christina Fleming as Chief Marketing Officer


Christina Fleming, Chief Marketing Officer, National Health Care Associates

Christina Fleming, Chief Marketing Officer, NHCA

I am thrilled to join the team at NHCA. I am committed to the development of my team, as well as playing a leading role in transforming the post-acute care journey for our patients and their families.

National Health Care Associates (NHCA) is pleased to name Christina Fleming as Chief Marketing Officer. Christina will play a critical role in ushering in a new chapter for NHCA as it reimagines the future of post-acute care.

“We are very excited to welcome Christina as a key member of our leadership team,” said Marvin Ostreicher, president of NHCA. “She is a talented executive with a depth of strategic marketing and customer service experience. We look forward to working with her as we explore opportunities for continued brand innovation.”

Christina’s expertise and long-standing track record will serve to bolster NHCA’s brand vision and strategic direction. She brings over 15 years of marketing and business development experience with an extensive portfolio in brand building, digital marketing, and sales leadership.

“I am thrilled to join the team at NHCA,” said Christina Fleming. “I am committed to the development of my team, as well as playing a leading role in transforming the post-acute care journey for our patients and their families.”

A transformational leader, she has developed marketing strategies driving results, delivering innovative solutions, and ensuring an enhanced customer experience in the post-acute care and senior living industries.

Before joining NHCA, Christina held various senior roles in healthcare. Most recently, she founded a boutique fractional marketing agency and built a customer service solution to aid senior living brands in using real-time feedback to drive marketing strategy. Prior, she served as vice president of marketing and business development for a multi-facility post-acute organization in New Jersey.

About National Health Care Associates: A leading provider of long-term care and short-term rehabilitation, National Health Care Associates operates a post-acute network of skilled nursing and assisted living centers throughout the northeast. NHCA’s 35-year legacy is grounded in its commitment to the highest quality of care, a focus on exceptional customer service, and providing a nurturing environment for patients, residents and their families. For more information, visit http://www.nhca.com.

Share article on social media or email:

Makes designing personalized prosthetics virtually more effective and even fun


UNYQ App that for the last 5 years has been successfully used to create and design thousands of prosthetic wears, guides the user and clinicians through the design and buying experience. Using state of the art photogrammetry software it enables the user to capture all the biometrics through an iPhone or an iPad. After orders are placed it informs the buyer when mock-ups are ready and order status, a process that takes 2 to 3 weeks from the time of final approval.

All lower limb UNYQ Covers, designs and colors are available on the app and now it includes a feature that enables virtual reordering of the covers without even visiting an UNYQ clinic.

“Selection, fitting and service of prosthetic wears are going virtual. The new version of the UNYQ App is particularly suitable in these times, giving users and clinicians the power to personalize prescription medical wears capturing biometrics remotely. The newly designed collections provide in these challenging times uplifting experience and are easy to take off to disinfect and put on again” said Eythor Bender CEO and Co-Founder of UNYQ.

The new app is available now to be downloaded from the Apple App store together with 9 new designs and new 2MM designs. The new 2MM covers that are available in 3 designs are more flexible and lighter than the original designs.

Detailed overview of the process and the features here in this blog: http://unyq.com/an-app-like-no-other/

ABOUT UNYQ

UNYQ is a designer of prescription prosthetic and orthotic wears. UNYQ uses digitization and 3D printing to enable mass customization and personalized design. UNYQ was founded in San Francisco and Seville Spain with over 700 UNYQ Clinics in over 30 countries across the world. To learn more about UNYQ, its Hub Network and complete product lines, visit http://www.unyq.com

Share article on social media or email:

Houston theater first to open its doors to patrons thanks to powerful UV-C decontamination technology


“The advanced technical solutions Apache SafeSpace Solutions provided have not only made our theater safer for our actors, artists, and audience, but have given us incredible peace of mind.”

Last month, for the first time since the global pandemic impacted citizens and businesses across the Houston area, A.D. Players at The George Theater opened their doors to patrons for a one-man offering from their educational touring department, “Apollo: to the Moon”, and an extended run of the concert, “Signed, Sealed, Delivered: John-Mark McGaha sings Stevie Wonder.” In addition to rigorous health and safety protocols, the theater worked with Apache SafeSpace Solutions to install custom UV-C treatment technology into their facility to help keep patrons safe. The technology has been integrated in educational, industrial, and commercial facilities all across the country, and is helping people safely get back to work and life.

“We are doing everything we can to keep our guests safe while still providing the magic of live entertainment. To our knowledge, we’re one of the first theaters in the country to reopen using this technology,” said Jake Speck, Executive Director of A.D. Players at The George. “The advanced technical solutions Apache SafeSpace Solutions provided have not only made our theater safer for our actors, artists, and audience, but have given us incredible peace of mind.”

The Apache SafeSpace Solutions team worked closely with the theater to design, fabricate, and install hospital-grade UV-C lights in the building’s HVAC system to scrub the building’s airflow of microbial threats like bacteria, viruses, and fungi. UV-C light has been proven to penetrate cell walls, breaking down the nucleus of the cell to destroy it, and businesses all over the country are utilizing it to treat and decontaminate surfaces and the air.

“The theater does so much for people’s mental and emotional health, especially during these strange and uncertain times. Our main goal is to get people back to life again, and the performing arts are a vital part of that,” said Mike Knigin, CEO of Apache Industrial Services. “We’re proud to support A.D. Players and help them create the safest environment possible for their guests.”

Since reopening, A.D. Players at The George has been putting on a variety of shows at the theater with limited audiences and strict health and safety protocols. Even with these extensive precautions in place, there is an understanding that some may not feel comfortable returning to the theater yet, so A.D. Players is offering a number of outdoor performances and livestreams that guests can enjoy from the comfort of their home. Further information can be found at http://www.adplayers.org.

Those interested in learning more about Apache SafeSpace Solutions and how the company’s advanced technical solutions can be integrated into their own home or business can visit http://www.apachesafespacesolutions.com for more information.

###

Share article on social media or email:

Jeff Krushell Interviews Thought Technology Ltd. Co-Founder Lawrence Klein on the Company’s History in the Field of Peak Performance Training


peak performance, biofeedback, neurofeedback, brain game

When you are able to measure the body’s physiological reaction to stress, you can learn to change how it responds and over time can call upon this skill whenever needed.

Podcaster and performance consultant, Jeff Krushell, interviews Thought Technology, Ltd Co-Founder, Lawrence Klein, in the final podcast of his series “The Krush Brain Game” where he explores the role of the brain body connection in optimal performance training.

Asked about his focus on the brain, Jeff replied, “We know the brain is a huge piece of the performance puzzle and new advances in technology are not only allowing us to map and track brain performance like never before but also allowing us to train the brain – IN REAL TIME and in ways that we have NEVER been able to until recently.”

Thought Technology’s products have been used by Olympic and professional athletes and other high performers for decades. A key component in peak performance training is learning to keep stress at bay, so that both mind and body can focus a hundred percent on the task at hand. According to Lawrence Klein, “Each individual processes stress differently. A psychophysiological stress assessment looks at multiple modalities such as heart rate, respiration rate, skin conductance, temperature, and muscle tension. When you are able to measure the body’s physiological reaction to stress, you can learn to change how it responds and over time can call upon this skill whenever needed.”

Included in this ongoing series, are interviews with several influential people from the biofeedback field including: Dr. Erik Peper, psychologist, author and president of the Biofeedback Federation of Europe; Dr. Inna Khazan who combines the use of biofeedback and mindfulness.

Click here to listen to Jeff Krushell’s interview with Lawrence Klein.

About Jeff Krushell

Jeff Krushell is the founder of Krush Performance and an Athlete Development Specialist & Organizational Performance Consultant. He is regarded as a noted expert in the area of talent development in sport and through his work has gained unique insights into the process of improving performance.

Over the last 25 years Jeff has worked in the world of high-performance sport helping athletes tap into their potential to truly understand what it is like to achieve Human Maximum Performance. Jeff currently consults for Major League Baseball International; CTV News, Edmonton; Vauxhall Baseball Academy; Link Management and has previously worked as the strength and conditioning coach for both the Toronto Blue Jays and Edmonton Eskimos.

About Lawrence Klein

In addition to being the Co- Founder of Thought Technology Ltd. with Dr. Hal Myers (1974), Lawrence Klein is:

  • Co-author in 1974 of Mind Over Muscle with Major Nory Laderoute
  • Member since 1965 of the CSCF/CSIA – Canadian Ski Coaches Association / Canadian Ski Instructors Alliance
  • Co- Founder in 1996 of The Biofeedback Federation of Europe
  • Life-time Member of the WTFCA – World Track & Field Coaches Associate


About Thought Technology Ltd.

Founded in 1975, Thought Technology is the world’s leading biofeedback and physiological instrument manufacturer. Its products are used as an essential part of many therapeutic treatments and clinical assessment protocols in over 85 countries and are used by tens of thousands of clinicians in thousands of medical institutions.

Always supportive of new research and development ideas, Thought Technology Ltd. has encouraged a number of special interest groups and clinicians to create cutting edge applications for its instrumentation. Thought Technology Ltd. equipment is now being used in telemedicine, web-based monitoring and biofeedback, sports training, research in human-machine interface, physiology-driven multimedia environments and virtual reality. Constantly striving to improve the quality of the products and services, TTL has obtained, and maintains, ISO 13485, and CE certification for the organization and products.

Share article on social media or email:

RadSite to Host Complimentary Webinar Featuring New Standards for Specialty Imaging


RadSite,™ a leading accrediting organization promoting performance and quality-based imaging practices, announced today that its next webinar will take place on Wednesday, December 9th, at 2:00 p.m. ET. The webinar is titled “An Overview of RadSite’s new MIPPA Accreditation Program Standards version 3.1.”

This webinar will feature an overview of RadSite’s revised Standards including the new specialty accreditation modules. The session will feature RadSite’s leadership and provide helpful insights to optimize the accreditation process. The presentation also will review several new standards development and public policy initiatives that RadSite is working on.

To register for the 60-minute webinar, click here.

The presentation will be moderated by Patrick D. Browning, MD, MA, MSL, RadSite’s Chief Medical Officer. The speakers will be:

  • Garry Carneal, JD, RadSite President & CEO
  • Eliot Siegel, MD, RadSite Chair, Standards Committee
  • Phillip W. Patton, PhD, CHP, DABR, DABSNM, RadSite Chief Physicist Officer
  • J ulie Irons, HIA, HCSA, RadSite Accreditation Manager

Currently, RadSite offers three MAP ADI accreditation programs covering CT, MRI, and Nuclear Medicine (i.e., PET, PET/CT and SPECT) imaging providers (also known as imaging suppliers). Successful RadSite applicants will continue to receive a general accreditation seal for each ADI modality but also may apply and be recognized for one or more clinical subspecialty areas under MAP Standards version 3.1.

The following RadSite specialty modules will be discussed during the webinar:

  • CT: Angiography, Body, Cardiac, Maxillofacial, Musculoskeletal, and Neurologic;
  • MRI: Angiography, Body, Breast, Cardiac, Functional, Musculoskeletal, and Neurologic; and
  • NucMed: Planar/SPECT – Cardiac and PET or PET/CT – Cardiac, Infection, Neurologic, Oncology.

Interested parties can download the new MAP Standards v 3.1 by clicking here. To register for the webinar that discusses the new v3.1 Standards, click here. To learn more about RadSite, visit http://www.radsitequality.com.

About RadSite™ (http://www.RadSiteQuality.com)

Founded in 2005, RadSite’s mission is to promote performance and quality-based practices for imaging systems across the U.S. and its territories. RadSite is recognized by the U.S. Centers for Medicare and Medicaid Services (CMS) as an official accreditation organization under the Medicare Improvements for Patients and Providers Act (MIPPA) of 2008. RadSite’s programs help assess, track, and report imaging trends in an effort to enhance imaging procedures and outcomes. RadSite also offers educational programs, publishes issue briefs, and underwrites research on a complimentary basis to raise awareness of patient safety issues and to promote best practices. The organization is governed by an independent board and committee system, which is open to a wide range of volunteers to ensure transparency and accountability. To learn more about RadSite, please contact us at (443) 440-6007 or info@radsitequality.com.

Share article on social media or email:

Benchmark Research: An Unparalleled Leadership Infrastructure


News Image

“Benchmark is thrilled to add such an industry powerhouse to our ranks that further establishes us as the most prominent platform-based research company in the United States.” CEO Mark Lacy

Benchmark Research, a leader in the medical research field, clinical vaccine trials and trusted ally in epidemiology, has been taking their firm to another level of success in the industry. In a bold move, Benchmark Research is very proud to announce the addition of Cynthia Dukes, PA, MT, as Chief Business Officer to Benchmark’s stellar leadership team. She is one of the premier world-recognized professionals in the vaccine industry, with over 40 years of diversified clinical experience. Cindy has extensive Site, Pharma, Biotech, and CRO experience across multiple therapeutic areas including vaccines, infectious diseases, oncology, and more. She is a distinguished Alumni of the Baylor College of Medicine for international contributions to vaccine and infectious disease. As well as receiving the Pharma Times Top 100 for contributions to vaccine and infectious disease, Top 50 Influential People in Vaccines, and Top Leader of ICON Clinical Research. As noted by CEO Mark Lacy, “Benchmark is thrilled to add such an industry powerhouse to our ranks that further establishes us as the most prominent platform-based research company in the United States.”

Cindy joins a truly outstanding leadership team composed of members with immense industry experience. This team includes Melissa Reynolds, RN, BSN, CCRC, Executive Vice President of Clinical Operations, who has more than 25 years’ experience in clinical research, including having directed two other research organizations and currently implementing all trial budget and contract management for Benchmark’s multiple locations. She is also a member of the Business Development Group and a slew of other vital functions within Benchmark Research.

Furthermore, Deborah Copeland, B.S., CCRC, CCRA, Chief Strategy Officer is a true blend of exceptionalism with over 35 years of industry experience, including similarly lofty positions such as Global Head of Quality Assurance for a major CRO, Executive Director of a Site Network, FDA Investigator, VP Head of Operations for a cardiovascular research company and Executive Director of Global Strategic Sourcing. Deborah has also served on impressive industry boards, such as the Clinical Global Advisory with the FDA, ACRP, the National Association of IRB Managers and many more. As well as receiving the Claudia Market Leadership Award, and Profile in Achievement in Clinical Research.

In addition, Jennifer Bacchi, SHRM-CP, CCRC, Vice President of Human Capital Management is an extraordinary talent, overseeing human resources as well as training and implementation of our employees. In addition to her over 25 years of experience in Clinical Research, Jennifer is also a published author, having written for ACRP’s industry news and many other publications.

Kim Brittain, Vice President of Strategic Development and Analytics has over 20 years of clinical research experience, overseeing marketing and study feasibility analysis. Her institutional knowledge and assessment of Benchmark’s capabilities is valuable to determining our success. Recently, under her oversight, marketing outreach efforts have resulted in the successful inclusion of 3,000+ volunteers in Benchmark’s coronavirus trials.

Finally, Van Johnson, Vice President of Business Development and Global Alliances is remarkably well known as one of the top five business development professionals within the industry. He is by far one of the most knowledgeable and sincere representatives of Benchmark’s ability to conduct clinical research trials. Significantly, Van is often a speaker at industry conferences and is a proud member of several URM (underrepresented minority) diversity committees including a committee member within STARR and a board member within MACRO, Benchmark’s very own diversity committee.

Lastly, in recent months Benchmark has received the greatest accolades in World Vaccine Congress history. Benchmark is the only participant in the Vaccine Industry Excellence Awards that has ever been awarded a win or runner-up status each and every year since the inception of the award. Additionally, Benchmark has also recently announced the exciting opening of our sixth site location in Los Angeles, California. The continuation of Benchmark’s global recognition for its outstanding quality and innovation in the field is due to our extraordinary infrastructure of leading professionals. Benchmark has raised the standard even higher and is proving to exceed the limits more than ever before.

Share article on social media or email:

Cancer Support Community CNJ Provides Virtual Education and Support to Teachers and Professionals


Strengthening Our Schools Conference

The virtual aspect of Strengthening Our Schools provided an opportunity to reach even more attendees than previous years. There were 92 attendees tuning in virtually from the comfort of their homes, offices, and classrooms from across the United States and internationally.

Children and teens impacted by a cancer diagnosis are experiencing increased fear, anxiety, and isolation due, not only to the diagnosis, but to the COVID-19 pandemic as well. Cancer Support Community Central New Jersey (CSCCNJ), a nonprofit organization located in Bedminster, NJ, understands the importance of providing support for these vulnerable students, as well as the school and childcare personnel with whom they spend the majority of their day. CSCCNJ recently hosted its annual Strengthening Our Schools conference virtually to equip school professionals with the tools they need when a child is impacted by a cancer diagnosis either personally or through a loved one.

CSCCNJ has remained a critical resource during this difficult time in partnership with Gilda’s Club South Jersey, Gilda’s Club Philadelphia, and Cancer Support Community Greater Lehigh Valley by modifying the in-person conference to be offered virtually and at no charge.

Now more than ever, these “kid-centered” professionals are on the front lines for students as they manage through a pandemic. The three-day series included breakout sessions on topics ranging from mindfulness and games to cancer, loss, and COVID-19. The series brought together a range of professionals from social workers and nurses to teachers and child life specialists, all of whom work with school-age children.

“There is an increased level of concern regarding mental health and quality of life, and this further exposed the myriad health disparities for our participants and their loved ones. There were families with young children in the home whose academics came to a halt and are now exposed to their parents’ cancer diagnosis and debilitating side effects 24/7,” says Katherine Schaible, LSW, Program Director at CSCCNJ.

The virtual aspect of the conference provided an opportunity to reach even more attendees than previous years. There were 92 attendees tuning in virtually from the comfort of their homes, offices, and classrooms from across the United States and internationally.

Strengthening Our Schools is the centerpiece of CSCCNJ’s efforts to address the significant unmet needs for adolescents and teens facing a cancer diagnosis or the diagnosis/death of a family member. Since 2013, this conference has provided tools and resources to professionals in these communities and made them aware of the services available to their schools.

Tara Geraghty, BA, REBT, presented a keynote speech on “Finding the Fun: Parenting in the Face of Cancer.” The presentation discussed what a parent and child experience in a pediatric cancer diagnosis. Tara made a point to answer any questions from these professionals as she added in how she felt and what worked best for her situation. By the end of the virtual conference, these professionals were equipped with tools and resources to bring back to their communities to better serve the children and families impacted by a cancer diagnosis.

“Before and during the pandemic, it has always been our mission to provide age and developmentally appropriate emotional and social support programs to children, teens, and families,” says Schaible.

This conference was made possible thanks to the generosity of Clinton Sunrise Rotary, Daiichi Sankyo, Sanofi US, and The Tyler Foundation.

For more information about School Based Support, contact Jesse Guzik, CCLS, Child/Youth Program Coordinator, at 908-658-5400 x5.

About Cancer Support Community Central New Jersey:

Cancer Support Community Central New Jersey (CSCCNJ) is a registered 501(c)(3). As experts in oncology mental health, the organization provides support, education, and hope to all people with cancer and their loved ones. Backed by evidence that the best cancer care includes social and emotional support, CSCCNJ creates a caring community to help individuals live with, through and beyond cancer. At no charge to people with cancer, family members, and caregivers, the organization delivers essential programs and services including individual and group support; educational, nutrition, and healthy-cooking workshops; classes to enhance health and wellness; and activities that build social connections. CSCCNJ has temporarily moved its program of support to a virtual platform since the start of stay-at-home orders, and will continue to provide both virtual and in-person support in the future. For more information, visit their website at cancersupportcnj.org or call (908) 658-5400.

Share article on social media or email: